Newsfeeds - Spark Newswire

1 minute read

Raymond James Maintains Outperform on Intercept Pharmaceuticals, Raises Price Target to $44

Today, 11:21 AM

Raymond James analyst Steven Seedhouse maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Outperform and raises the price target from $40 to $44.

ICPT

6 minute read

86 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:21 AM

Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million.

ACI

4 minute read

54 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 11:21 AM

Gainers iRhythm Technologies, Inc. (NASDAQ: IRTC) climbed 38.9% to $106.64. iRhythm Technologies commented on the Centers for Medicare and Medicaid Services (CMS) Calendar Year 2022 Medicare Physician Fee Schedule (MPFS) Final Rule.

ACI

2 minute read

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

Today, 11:21 AM

AGRX

1 minute read

Intercept Pharmaceuticals Q3 EPS $(0.63) Beats $(1.09) Estimate, Sales $92.83M Beat $83.02M Estimate

By Benzinga Newsdesk

Today, 11:21 AM

Intercept Pharmaceuticals (NASDAQ:ICPT) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(1.09) by 42.2 percent. This is a 60.87 percent increase over losses of $(1.61) per

ICPT

25 minute read

Earnings Scheduled For November 3, 2021

By Benzinga Insights

Today, 11:21 AM

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.

AAWW

2 minute read

Events
News

Intercept Announces Late-Breaking Oral Presentation And Poster Presentations At The Liver Meeting

By Benzinga Newsdesk

Today, 11:21 AM

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that

ICPT

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 11:21 AM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

Today, 11:21 AM

Gainers

ACRS

5 minute read

58 Biggest Movers From Friday

By Lisa Levin

Today, 11:21 AM

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.

AMRS